GMP Sites in China and India: A Comparison
Last week we discussed the similarities and differences between pharmaceutical GMP sites located in China and India with regards to compliance with FDA requirements. This week the Regulatory Affairs Professionals Society (RAPS) published a much more detailed comparison from a different perspective, the review of a few FDA 483s issued to Chinese companies in 2015. Overall country-wide quality of … Read more